The Erythropoietin/Erythropoietin Receptor Signaling Pathway Promotes Growth and Invasion Abilities in Human Renal Carcinoma Cells

• Pengjie Wu,

  Affiliation Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, People’s Republic of China

  ⨯
• Ning Zhang,

  Affiliation Department of Urology, Beijing Chaoyang Hospital, Capital University of Medicine Science, Beijing, People’s Republic of China

  ⨯
• Xi Wang,

  Affiliation Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, People’s Republic of China

  ⨯
• Chi Zhang,

  Affiliation Department of General Surgery, Peking University First Hospital, Beijing, People’s Republic of China

  ⨯
• Teng Li,

  Affiliation Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, People’s Republic of China

  ⨯
• Xianghui Ning,

  Affiliation Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, People’s Republic of China

  ⨯
• Kan Gong

  * E-mail: gongkan2004@yahoo.com.cn

  Affiliation Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, People’s Republic of China

  ⨯